0 Items - $0.00
A to Z

Rp-8-Cl-cAMPS

8- Chloroadenosine- 3', 5'- monophosphorothioate, Rp- isomer ( Rp-8-Cl-cAMPS ), sodium salt
Membrane-permeant analogue of the cyclic AMP antagonist Rp-cAMPS
Cat. No.: C 003
    
CAS No.: [142754-27-6]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: C 003-05
Unit: 5 µmol / ~2 mg
$330.00
For other salt forms please inquire. Site-selective, competitive inhibitor of protein kinase A (cyclic AMP antagonist) with preference for type I of protein kinase A. Resistant against mammalian cyclic nucleotide-dependent phosphodiesterases. Significantly more lipophilic and membrane-permeant compared to Rp-cAMPS. Detailed technical information and updated reference list available on request. Reference: Yokozaki et al., Cancer Res., 52, 2504 - 2508 (1992).
Cat. No. C 003
CAS number [142754-27-6]
Purity > 99% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₀H₁₀ClN₅O₅PS · Na
Molecular weight [g/mol] 401,7
cAMP modified at the exocyclic oxygen equatorial (Rp-)
Modifications 8-cAMP
Target PKA (cAK) Inhibitor
Lipophilicity 1.43
Absorption max [nm] 262
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 17000
  • 1. Soto I., Rosenthal J. J. C., Blagburn J. M.Blanco R. E., J. Neurochem., 96, 82 - 96 (2006), "Fibroblast Growth Factor 2 Applied to the Optic Nerve After Axotomy Up-regulates BDNF and TrkB in Ganglion Cells by Activating the ERK and PKA Signaling Pathways"
  • 2. van Bemmelen M. X. P., Szczepanska-Konkel M., Jastorff B., Jankowski M.Angielski S., J. Physiol. Pharmacol., 56, 111 - 120 (2005), "Effect of cAMP Analogues on Glomerular Inulin Space of Isolated Rats Renal Glomeruli"
  • 3. Cancedda L., Putignano E., Impey S., Maffei L., Ratto G. M.Pizzorusso T., J. Neurosci., 23, 7012 - 7020 (2003), "Patterned Vision Causes CRE-mediated Gene Expression in the Visual Cortex through PKA and ERK"
  • 4. Locatelli F., Maldonado H.Romano A., Neurobiol. Learn. Mem., 77, 234 - 249 (2002), "Two Critical Periods for cAMP-dependent Protein Kinase Activity During Long-Term Memory Consolidation in the Crab Chasmagnathus"
  • 5. Constantinescu A., Gordon A. S.Diamond I., J. Biol. Chem., 277, 18810 - 18816 (2002), "cAMP-dependent Protein Kinase Types I and II Differentially Regulate cAMP Response Element-mediated Gene Expression. Implications for Neuronal Responses to Ethanol"
  • 6. Beaver C. J., Ji Q. H., Fischer Q. S.Daw N. W., Nature Neurosci., 4, 159 - 163 (2001), "Cyclic AMP-dependent Protein Kinase Mediates Ocular Dominance Shifts in Cat Visual Cortex"
  • 7. Flores-Hernandez J., Hernandez S., Snyder G. L., Yan Z., Fienberg A. A., Moss S. J., Greengard P.Surmeier D. J., J. Neurophysiol., 83, 2996 - 3004 (2000), "D-1 Dopamine Receptor Activation Reduces GABA(A) Receptor Currents in Neostriatal Neurons through a PKA/DARPP-32/PP1 Signaling Cascade"
  • 8. Christensen A., Dao K. K., Doeskeland S. O., Schwede F., Jastorff B., Genieser H.-G., de Rooij J., Bos J. L., Rehmann H., Kraemer A.Wittinghofer A., 12th Protein Kinase Symp. NO/cGMP and Protein Kinase Signaling Bad Brückenau/Germany, 0, 0 - 0 (2000), "8-Modified cAMP Analogs give Insight into the Geometries of the cAMP Binding Sites of RI, RII and EPAC-1"
  • 9. Johansson C., Aandahl E. M., Aukrust P., Müller F., Hansson V., Froeland S. S.Tasken K., 12th Protein Kinase Symp. NO/cGMP and Protein Kinase Signaling Bad Brückenau/Germany, 0, 0 - 0 (2000), "Protein Kinase A Type I Antagonist as an Immune-Modulating Therapy"
  • 10. Schwede F., Maronde E., Genieser H.-G.Jastorff B., Pharmacol. Ther., 87, 199 - 226 (2000), "Cyclic Nucleotide Analogs as Biochemical Tools and Prospective Drugs"
  • 11. Liu S. L., Rao Y.Daw N., Cereb. Cortex., 13, 864 - 69 (2000), "Roles of Protein Kinase A and Protein Kinase G in Synaptic Plasticity in the Visual Cortex"
  • 12. Francis S. H.Corbin J. D., Crit. Rev. Clin. Lab. Sci., 36, 275 - 328 (1999), "Cyclic Nucleotide-Dependent Protein Kinases: Intracellular Receptors for cAMP and cGMP Action"
  • 13. Pfeifer A., Ruth P., Dostmann W., Sausbier M., Klatt P.Hofmann F., in Rev. Physiol. Biochem. Pharmacol. Berlin / Springer, 135, 105 - 149 (1999), "Structure and Function of cGMP-Dependent Protein Kinases"
  • 14. Cho-Chung Y. S., Jastorff B.Genieser H.-G., USA patent 5916, 843, 0 - 0 (1998), "Cyclic AMP Analogues, Individually and in Pairs, to Inhibit Neoplastic Cell Growth"
  • 15. Braun C. M., Huang S.-K., Kagey-Sobotka A., Lichtenstein L. M.Essayan D. M., Biochem. Pharmacol., 56, 871 - 879 (1998), "Co-Regulation of Antigen-Specific T Lymphocyte Responses by Type I and Type II Cyclic AMP-Dependent Protein Kinases (CAK)"
  • 16. Tasken K., Aandahl E. M., Aukrust P., Müller F., Froland S. S.Hansson V., Intl. Patent Appl. PCT, 0, 0 - 0 (1998), "Use of Immunomodulating Agents"
  • 17. Maronde E., Middendorff R., Telgmann R., Müller D., Hemmings B., Tasken K.Olcese J., J. Neurochem., 68, 770 - 777 (1997), "Melatonin Synthesis in the Bovine Pineal Gland is Regulated by Type II Cyclic AMP-Dependent Protein Kinase"
  • 18. Rohlff C., Ahmad S., Borellini F., Lei J.Glazer R. I., J. Biol. Chem., 272, 21137 - 21141 (1997), "Modulation of Transcription Factor Sp1 by cAMP-dependent Protein Kinase"
  • 19. Svensson S. P. S., Adolfsson P. I., Grundstrom N.Karlsson J. O. G., Pigm. Cell Res., 10, 395 - 400 (1997), "Multiple Alpha(2)-Adrenoceptor Signalling Pathways Mediate Pigment Aggregation within Melanophores"
  • 20. Maldonado H., Romano A.Tomsic D., Braz. J. Med. Biol. Res., 30, 813 - 826 (1997), "Long-term Habituation (LTH) in the Crab Chasmagnathus: a Model for Behavioral and Mechanistic Studies of Memory"
  • 21. Romano A., Locatelli F., Delorenzi A., Pedreira M. E.Maldonado H., Brain Res., 735, 131 - 140 (1996), "Effects of Activation and Inhibition of cAMP-dependent Protein Kinase on Long-term Habituation in the Crab Chasmagnathus"
  • 22. Rohlff C.Glazer R. I., Cell. Signal., 7, 431 - 443 (1996), "Regulation of Multidrug Resistance Through the cAMP and EGF Signalling Pathways"
  • 23. Hemmings H. C., in Regulatory Protein Modification: Techniques and Protocols H.C. Hemmings (ed.) Humana Press Inc., 0, 121 - 218 (1996), "Protein Kinase and Phosphatase Inhibitors. Applications in Neuroscience"
  • 24. Srivastava R. K., Srivastava A. R.Cho-Chung J.-S., Int. J. Oncol., 9, 879 - 884 (1996), "Multidrug Resistance in Cancer"
  • 25. Herrero I.Sanchez-Prieto J., J. Biol. Chem., 271, 30554 - 30560 (1996), "cAMP-Dependent Facilitation of Glutamate Release by Beta-Adrenergic Receptors in Cerebrocortical Nerve Terminals"
  • 26. Bito H., Deisseroth K.Tsien R. W., Cell, 87, 1203 - 1214 (1996), "CREB Phosphorylation and Dephosphorylation: A Ca²+- and Stimulus Duration-Dependent Switch for Hippocampal Gene Expression"
  • 27. Bayliss M. A., Pereira L., Games D. E., Brenton A. G., Harris F. M., Newton R. P.Walton T. J., Proc. 2. MS-Pharmaday Siena Italy #C 17-67 - 68, 0, 67 - 68 (1996), "Fast-Atom Bombardment Mass Spectrometry of Site-Specific Effectors of Cyclic Nucleotide Dependent Protein Kinases"
  • 28. Romano A., Delorenzi A., Pedreira M. E., Tomsic D.Maldonado H., Behav. Brain Res., 75, 119 - 125 (1996), "Acute Administration of a Permeant Analog of cAMP and a Phosphodiesterase Inhibitor Improve Long-term Habituation in the Crab Chasmagnathus"
  • 29. Yu S.-M., Cheng Z.-J.Kuo S.-C., Br. J. Pharmacol., 114, 1227 - 1235 (1995), "Antiproliferative Effects of A02011-1, an Adenylate Cyclase Activator, in Cultured Vascular Smooth Muscle Cells of Rat"
  • 30. Gjertsen B. T., Mellgren G., Otten A., Maronde E., Genieser H.-G., Jastorff B., Vintermyr O. K., McKnight G. S.Doeskeland S. O., J. Biol. Chem., 270, 20599 - 20607 (1995), "Novel (Rp)-cAMPS Analogs as Tools for Inhibition of cAMP-Kinase in Cell Culture"
  • 31. Ruchaud S., Zorn M., Davilar-Villar E., Genieser H.-G., Hoffmann C., Gjertsen B. T., Doeskeland S. O., Jastorff B.Lanotte M., Cell. Pharmacol., 2, 127 - 140 (1995), "Evidence for Several Pathways of Biological Response to Hydrolysable cAMP-Analogues Using a Model System of Apoptosis in IPC-81 Leukaemia Cells"
  • 32. Muresan S., Bologa C., Mracec M., Chiriac A., Jastorff B., Simon Z.Naray-Szabo G., J. Mol. Struct., 342, 161 - 171 (1995), "Comparative QSAR Study with Electronic and Steric Parameters for cAMP Derivatives with Large Substituents in Positions 2, 6 and 8"
  • 33. Huang Y. Y., Li X. C.Kandel E. R., Cell, 79, 69 - 79 (1994), "cAMP Contributes to Mossy Fiber LTP by Initiating Both a Covalently Mediated Early Phase and Macromolecular Synthesis-dependent Late Phase"
  • 34. Muresan S., Bologa C., Chiriac A., Jastorff B., Kurunczi L.Simon Z., Quant. Struct.-Act. Relat., 13, 242 - 248 (1994), "Comparative Structure-Affinity Relations by MTD for Binding of Cycloadenosine Monophosphate Derivatives to Protein Kinase Receptors"
  • 35. Ruchaud S., Duprez E., Gendron M.-C., Houge G., Genieser H.-G., Jastorff B., Doeskeland S. O.Lanotte M., Proc. Natl. Acad. Sci. USA, 91, 8428 - 8432 (1994), "Two Distinctly Regulated Events, Priming and Triggering, During Retinoid-induced Maturation and Resistance of NB4 Promyelocytic Leukemia Cell Line"
  • 36. Glazer R. I.Rohlff C., Breast Cancer Res. Treat., 31, 263 - 271 (1994), "Transcriptional Regulation of Multidrug Resistance in Breast Cancer"
  • 37. Klyszcz-Nasko H., Richter-Landsberg C.Beyersmann D., Arch. Biochem. Biophys., 306, 383 - 390 (1993), "Modulation of Bradykinin-induced Calcium Signals by Oxidative Stress in PC12 Cells"
  • 38. Naß N., Colling C., Cramer M., Genieser H.-G., Butt E., Winkler E., Jaenicke L.Jastorff B., Biochem. J., 285, 129 - 136 (1992), "Mapping of the Epitope/Paratope Interactions of a Monoclonal Antibody Directed Against Adenosine- 3', 5'- monophosphate"
  • 39. Jastorff B., Proceeding of the 8th. Internatl. Conference on Second Messengers & Phosphoproteins UK, 0, 0 - 0 (1992), "A New Generation of Cyclic Nucleotide Analogues : Site Specific, Enzyme Selective, Agonistic or Antagonistic and Resistant to Hydrolysis"
  • 40. Yokozaki H., Tortora G., Pepe S., Maronde E., Genieser H.-G., Jastorff B.Cho- Chung Y. S., Cancer Res., 52, 2504 - 2508 (1992), "Unhydrolysable Analogs of Cyclic Adenosine- 3', 5' - Monophosphate Demonstrating Growth Inhibition and Differentiation in Human Cancer Cells"
  • 41. Jastorff B., Maronde E., van Bemmelen M. X. P., Zorn M.Störmann R., Proc. 3rd Intl. Symp. Mol. Aspects Chemother. Poland, PWN Warsaw & Springer Verlag New York, 0, 57 - 87 (1991), "Cyclic Nucleotide Metabolism as a Target in Chemotherapy"

Show more